Literature DB >> 8264725

Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan.

A Shankar1, T K Mitchen, L R Hall, S J Turco, R G Titus.   

Abstract

An attenuated clone of Leishmania major was produced by chemical mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine and was biochemically characterized to determine the reason(s) for its loss of virulence. We found that the degree of virulence of L. major did not correlate with either the level of expression of promastigote surface protease (PSP) or with the enzymatic activity of the molecule. In contrast, the levels of lipophosphoglycan (LPG) expressed by the attenuated clone were found to be at least 6-fold less than those of virulent L. major. When the attenuated L. major was injected into BALB/c mice and allowed to revert to virulence, the degree of reversion to virulence that the parasites underwent correlated directly with the amount and form (metacyclic) of LPG expressed by the parasites. Thus, these results further implicate LPG as an important Leishmania virulence factor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264725     DOI: 10.1016/0166-6851(93)90067-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  5 in total

1.  Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.

Authors:  C Kébaïer; H Louzir; M Chenik; A Ben Salah; K Dellagi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors.

Authors:  J C Mottram; A E Souza; J E Hutchison; R Carter; M J Frame; G H Coombs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes.

Authors:  M B Seay; P L Heard; G Chaudhuri
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Development of a safe live Leishmania vaccine line by gene replacement.

Authors:  R G Titus; F J Gueiros-Filho; L A de Freitas; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  Characterization of a subunit of the outer dynein arm docking complex necessary for correct flagellar assembly in Leishmania donovani.

Authors:  Simone Harder; Meike Thiel; Joachim Clos; Iris Bruchhaus
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.